Details van artikel 223 van 350 gevonden artikelen
P-052: Measurable residual disease (MRD) dynamics during maintenance with ixazomib vs placebo in 1280 newly diagnosed multiple myeloma (NDMM) patients: a pooled analysis of the TOURMALINE-MM3 and -MM4 trials
Titel:
P-052: Measurable residual disease (MRD) dynamics during maintenance with ixazomib vs placebo in 1280 newly diagnosed multiple myeloma (NDMM) patients: a pooled analysis of the TOURMALINE-MM3 and -MM4 trials
Auteur:
Paiva, Bruno Manrique, Irene Dimopoulos, Meletios A. Gay, Francesca Min, Chang-Ki Zweegman, Sonja Špička, Ivan Teipel, Raphael Mateos, María-Victoria Giuliani, Nicola Cavo, Michele Hopkins, Christine Rojas Fun, Weijun Suryanarayan, Kaveri Vorog, Alexander Li, Cong Wang, Bingxia Estevam, Jose Labotka, Richard Dash, Ajeeta
Verschenen in:
Clinical lymphoma myeloma and leukemia
Paginering:
Jaargang 22 () nr. S pagina's S63-S64
Jaar:
2022
Inhoud:
Uitgever:
Elsevier Inc.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 223 van 350 gevonden artikelen